152 related articles for article (PubMed ID: 17349694)
41. Preclinical testing of a vaccine candidate against tularemia.
Suresh RV; Ma Z; Sunagar R; Bhatty V; Banik S; Catlett SV; Gosselin EJ; Malik M; Bakshi CS
PLoS One; 2015; 10(4):e0124326. PubMed ID: 25897786
[TBL] [Abstract][Full Text] [Related]
42. Francisella tularensis vaccines.
Griffin KF; Oyston PC; Titball RW
FEMS Immunol Med Microbiol; 2007 Apr; 49(3):315-23. PubMed ID: 17316369
[TBL] [Abstract][Full Text] [Related]
43. Th17 cytokines in recall responses against Francisella tularensis in humans.
Paranavitana C; Zelazowska E; DaSilva L; Pittman PR; Nikolich M
J Interferon Cytokine Res; 2010 Jul; 30(7):471-6. PubMed ID: 20626289
[TBL] [Abstract][Full Text] [Related]
44. Signatures of T cells as correlates of immunity to Francisella tularensis.
Eneslätt K; Normark M; Björk R; Rietz C; Zingmark C; Wolfraim LA; Stöven S; Sjöstedt A
PLoS One; 2012; 7(3):e32367. PubMed ID: 22412866
[TBL] [Abstract][Full Text] [Related]
45. Francisella tularensis vaccines.
Oyston PC
Vaccine; 2009 Nov; 27 Suppl 4():D48-51. PubMed ID: 19837286
[TBL] [Abstract][Full Text] [Related]
46. Elucidation of a mechanism of oxidative stress regulation in Francisella tularensis live vaccine strain.
Ma Z; Russo VC; Rabadi SM; Jen Y; Catlett SV; Bakshi CS; Malik M
Mol Microbiol; 2016 Sep; 101(5):856-78. PubMed ID: 27205902
[TBL] [Abstract][Full Text] [Related]
47. Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis.
Waag DM; Galloway A; Sandstrom G; Bolt CR; England MJ; Nelson GO; Williams JC
J Clin Microbiol; 1992 Sep; 30(9):2256-64. PubMed ID: 1400988
[TBL] [Abstract][Full Text] [Related]
48. Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.
Karttunen R; Surcel HM; Andersson G; Ekre HP; Herva E
J Clin Microbiol; 1991 Apr; 29(4):753-6. PubMed ID: 1909711
[TBL] [Abstract][Full Text] [Related]
49. Itaconate indirectly influences expansion of effector T cells following vaccination with Francisella tularensis live vaccine strain.
Roberts LM; Leighton I; Schwarz B; Wehrly TD; Evans TJ; Bosio CM
Cell Immunol; 2022 Mar; 373():104485. PubMed ID: 35149415
[TBL] [Abstract][Full Text] [Related]
50. Francisella tularensis selectively induces proinflammatory changes in endothelial cells.
Forestal CA; Benach JL; Carbonara C; Italo JK; Lisinski TJ; Furie MB
J Immunol; 2003 Sep; 171(5):2563-70. PubMed ID: 12928407
[TBL] [Abstract][Full Text] [Related]
51. Current vaccine strategies and novel approaches to combatting Francisella infection.
Harrell JE; Roy CJ; Gunn JS; McLachlan JB
Vaccine; 2024 Apr; 42(9):2171-2180. PubMed ID: 38461051
[TBL] [Abstract][Full Text] [Related]
52. Long-lasting cell-mediated immunity induced by a live Francisella tularensis vaccine.
Tärnvik A; Löfgren ML; Löfgren S; Sandström G; Wolf-Watz H
J Clin Microbiol; 1985 Oct; 22(4):527-30. PubMed ID: 3878364
[TBL] [Abstract][Full Text] [Related]
53. Current status of vaccine development for tularemia preparedness.
Hong KJ; Park PG; Seo SH; Rhie GE; Hwang KJ
Clin Exp Vaccine Res; 2013 Jan; 2(1):34-9. PubMed ID: 23596588
[TBL] [Abstract][Full Text] [Related]
54. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens.
Abraham A; Ostroff G; Levitz SM; Oyston PCF
Clin Exp Immunol; 2019 Nov; 198(2):143-152. PubMed ID: 31400225
[TBL] [Abstract][Full Text] [Related]
55. Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis.
Tärnvik A; Holm SE
Infect Immun; 1978 Jun; 20(3):698-704. PubMed ID: 307538
[TBL] [Abstract][Full Text] [Related]
56.
De Pascalis R; Bhargava V; Espich S; Wu TH; Gelhaus HC; Elkins KL
Front Microbiol; 2023; 14():1224480. PubMed ID: 37547680
[TBL] [Abstract][Full Text] [Related]
57. Molecular cloning and expression of a T-cell stimulating membrane protein of Francisella tularensis.
Sjöstedt A; Sandström G; Tärnvik A; Jaurin B
Microb Pathog; 1989 Jun; 6(6):403-14. PubMed ID: 2475738
[TBL] [Abstract][Full Text] [Related]
58. Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine.
Chang YH; Duong DM; Goll JB; Wood DC; Jensen TL; Yin L; Gelber CE; Seyfried NT; Anderson E; Natrajan MS; Rouphael N; Johnson RA; Sanz P; Mulligan MJ; Hoft DF
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32722207
[No Abstract] [Full Text] [Related]
59. Transcriptomic and Metabolic Responses to a Live-Attenuated
Goll JB; Li S; Edwards JL; Bosinger SE; Jensen TL; Wang Y; Hooper WF; Gelber CE; Sanders KL; Anderson EJ; Rouphael N; Natrajan MS; Johnson RA; Sanz P; Hoft D; Mulligan MJ
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32722194
[TBL] [Abstract][Full Text] [Related]
60. [Evaluation of tularemia vaccine strains in experiments on rabbits].
Sirotiuk LV
Zh Mikrobiol Epidemiol Immunobiol; 1974 Jul; (7):118-21. PubMed ID: 4454858
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
